Patent · US Active

Reversibly blocked nucleoside analogues and their use

US10988501B2 · kind B2 · utility

2Cited by
2References
18Claims
0Family size

Assignees

Inventors

Key dates

Filing dateApr 21, 2017
Grant dateApr 27, 2021
Priority date
Expiry dateOct 15, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q1/6869
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Reversibly blocked nucleoside analogues and methods of using such nucleoside analogues for sequencing of nucleic acids are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.